Skip to Content
Merck
  • A mutation in the CASQ1 gene causes a vacuolar myopathy with accumulation of sarcoplasmic reticulum protein aggregates.

A mutation in the CASQ1 gene causes a vacuolar myopathy with accumulation of sarcoplasmic reticulum protein aggregates.

Human mutation (2014-08-15)
Daniela Rossi, Bianca Vezzani, Lucia Galli, Cecilia Paolini, Luana Toniolo, Enrico Pierantozzi, Simone Spinozzi, Virginia Barone, Elena Pegoraro, Luca Bello, Giovanna Cenacchi, Gaetano Vattemi, Giuliano Tomelleri, Giulia Ricci, Gabriele Siciliano, Feliciano Protasi, Carlo Reggiani, Vincenzo Sorrentino
ABSTRACT

A missense mutation in the calsequestrin-1 gene (CASQ1) was found in a group of patients with a myopathy characterized by weakness, fatigue, and the presence of large vacuoles containing characteristic inclusions resulting from the aggregation of sarcoplasmic reticulum (SR) proteins. The mutation affects a conserved aspartic acid in position 244 (p.Asp244Gly) located in one of the high-affinity Ca(2+) -binding sites of CASQ1 and alters the kinetics of Ca(2+) release in muscle fibers. Expression of the mutated CASQ1 protein in COS-7 cells showed a markedly reduced ability in forming elongated polymers, whereas both in cultured myotubes and in in vivo mouse fibers induced the formation of electron-dense SR vacuoles containing aggregates of the mutant CASQ1 protein that resemble those observed in muscle biopsies of patients. Altogether, these results support the view that a single missense mutation in the CASQ1 gene causes the formation of abnormal SR vacuoles containing aggregates of CASQ1, and other SR proteins, results in altered Ca(2+) release in skeletal muscle fibers, and, hence, is responsible for the clinical phenotype observed in these patients.

MATERIALS
Product Number
Brand
Product Description

Roche
X-tremeGENE HP DNA Transfection Reagent, High-performance polymer reagent for transfecting many cell lines